• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.02
  • VXN 16.95
  • VXO 14.44
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)

Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

Company Profile

Abiomed, Inc. and its subsidiaries manufacture and sell medical devices in circulatory support that offer a continuum of care in heart recovery to acute heart failure patients. It offers various disposable products for the surgery suite, which comprise BVS 5000 blood pump and AB5000 ventricle for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis; integrated cannula system that connects the ventricle or blood pump to the heart and an associated artery; and Impella LD that provides temporary left ventricular assist devices support for recovery from post-cardiotomy hemodynamic instability and cardiogenic shock. The company also provides disposable products for the cardiac catheterization lab and the surgery suite that include Impella 2.5 and 5.0 catheters, which are percutaneous micro heart pumps with integrated motors and sensors for use in interventional cardiology and heart surgery; and IAB, a percutaneous intra-aortic balloon used to support various prophylactic, pre-shock, and profound shock conditions. In addition, it offers driver console products, such as AB5000 console for BVS 5000 blood pump and AB5000 ventricle; mobile pump consoles for Impella products; iPulse console, a multi-purpose driver console for IAB, AB5000, BVS 5000, and other manufacturers? IABs; and portable discharge driver for AB5000 for in-hospital and out-of-hospital patients. Further, Abiomed provides AbioCor implantable replacement heart, a self-contained artificial heart for severe biventricular heart failure. It sells its products through direct sales representatives and clinical support personnel in the United States, Germany, France, the United Kingdom, and Ireland; and internationally. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

ABMD (Abiomed Inc)
Last Trade 182.98 Date 1/24/2020
Change % -0.81 % Price Change -1.48
Open 185.14 52 Week High 364.31
High 187.5 52 Week Low 155.02
Low 181.56 Type stock
Volume 557906 Average Volume 904253
Prev Close 184.46 Stock Exchange NASDAQ
Bid 182.0 Ask 182.98
Bid Size 2 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 21.9567 Book Value Yield 0.12
Buy Back Yield CAPE Ratio 117.3342
Cash Return 0.031 Cash Flow per Share 6.1603
Cash Flow Yield 0.0337 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield 0.0262 EV/EBIT 31.4383
EV/EBITDA 29.4457 EV / Free Cash Flow 32.2188
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income 27.5703
EV / Revenue 9.5298 EV / Total Asset 6.9526
Expected Dividend Growth Rate Free Cash Flow per Share 5.2648
Free Caash Flow Ratio 34.755167 Free Cash Flow Yield 0.0288
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio 39.731835 Payout Ratio 0.0
PB Ratio 8.333676 PB Ratio 10 Year Growth 0.112267
PB Ratio 3 Year Growth 15.659749 Cash Ratio 3 Year Average 3140.7907
Price to Cash Flow Ratio 29.70324 PEG Payback
PEG Ratio PE Ratio 38.200418
PE Ratio 10 Year Average 107.553864 PE Ratio 10 Year Growth
PE Ratio 10 Year High 615.5 PE Ratio 10 Year Low 22.513208
PE Ratio 1 Year Avg 46.708508 PE Ratio 1 Year High 84.59322
PE Ratio 1 Year Low 28.499106 PE Ratio 3 Year Avg 91.715923
PE Ratio 5 Year Avg 86.725539 PE Ratio 5 Year High 182.126531
PE Ratio 5 Year Low 22.513208 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 89.963584 Price Change 1 Month 1.07263
Price to Cash Ratio 18.554032 Price / EBITDA 31.763738
Price to Sales Ratio 10.280027 Price to Sales Ratio 10 Year Growth 0.105742
Price to Sales Ratio 3 Year Avg 18.394587 Price to Sales Ratio 5 Year Avg 86.725539
Sale per Share 17.7996 Sales Yield 0.0973
Sustainable Growth Rate 0.2475 Tangible Book Value per Share 20.9263
Tangible Book Value per Share 3 year Avg 16.651 Tangible Book Value per Share 5 year Avg 12.9371
Total Asset per Share 24.8997 Total Yield
Working Capital per Share 11.8525 Working Capital per Share 3 Year Avg 9.8091
Working Capital per Share 5 Year Avg 8.2056 Beta 0.982226